Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annalisa Aratari

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Nuclear Medicine Communications|June 9, 2005
Inflammatory bowel diseases: clinical update of practical guidelinesAngelo Viscido, Annalisa Aratari, Francesca Maccioni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 17, 2011
Do not disturb the sleeping wormFederica Fascì Spurio, Annalisa Aratari, Giuseppe Emilio Bazuro, et al.
Recenti Progressi in Medicina|December 16, 2015
[Evolving therapeutic targets in inflammatory Bowel Disease: mucosal healing as an emerging end point]Giovanna Condino, Giovanna Margagnoni, Annalisa Aratari, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Methotrexate-induced pneumonitis in a patient with Crohn's diseaseGiovanna Margagnoni, Valeria Papi, Annalisa Aratari, et al.
Recenti Progressi in Medicina|February 17, 2018
[Towards new therapeutic paradigms beyond symptom control in the management of inflammatory bowel diseases.]Stefano Festa, Giulia Zerboni, Annalisa Aratari, et al.
Multidisciplinary Respiratory Medicine|September 11, 2012
Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literatureNadia D'Andrea, Luca Triolo, Giovanna Margagnoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 24, 2021
No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experienceFabiola De Biasio, Annalisa Aratari, Stefano Festa, et al.
Recenti Progressi in Medicina|May 30, 2019
[The advantages of patient's active involvement in the management of chronic Inflammatory Bowel Diseases.]Giulia Zerboni, Stefano Festa, Annalisa Aratari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2020
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concernsStefano Festa, Annalisa Aratari, Fabiola De Biasio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2020
The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When "non-urgent" does not mean "deferrable"Daniela Pugliese, Claudio Papi, Giuseppe Privitera, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Nuclear Medicine Communications|June 9, 2005
Inflammatory bowel diseases: clinical update of practical guidelinesAngelo Viscido, Annalisa Aratari, Francesca Maccioni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 17, 2011
Do not disturb the sleeping wormFederica Fascì Spurio, Annalisa Aratari, Giuseppe Emilio Bazuro, et al.
Recenti Progressi in Medicina|December 16, 2015
[Evolving therapeutic targets in inflammatory Bowel Disease: mucosal healing as an emerging end point]Giovanna Condino, Giovanna Margagnoni, Annalisa Aratari, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Methotrexate-induced pneumonitis in a patient with Crohn's diseaseGiovanna Margagnoni, Valeria Papi, Annalisa Aratari, et al.
Recenti Progressi in Medicina|February 17, 2018
[Towards new therapeutic paradigms beyond symptom control in the management of inflammatory bowel diseases.]Stefano Festa, Giulia Zerboni, Annalisa Aratari, et al.
Multidisciplinary Respiratory Medicine|September 11, 2012
Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literatureNadia D'Andrea, Luca Triolo, Giovanna Margagnoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 24, 2021
No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experienceFabiola De Biasio, Annalisa Aratari, Stefano Festa, et al.
Recenti Progressi in Medicina|May 30, 2019
[The advantages of patient's active involvement in the management of chronic Inflammatory Bowel Diseases.]Giulia Zerboni, Stefano Festa, Annalisa Aratari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2020
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concernsStefano Festa, Annalisa Aratari, Fabiola De Biasio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2020
The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When "non-urgent" does not mean "deferrable"Daniela Pugliese, Claudio Papi, Giuseppe Privitera, et al.
Pageof 6